<DOC>
	<DOCNO>NCT02401204</DOCNO>
	<brief_summary>Infections multiply antibiotic-resistant bacteria represent major cause preventable morbidity mortality amongst hospitalize neonate worldwide . In Southeast Asia , antibiotic-resistance major problem , Gram-negative bacteria account majority infection . The common pathogen Acinetobacter spp. , Pseudomonas aeruginosa , Enterobacter spp. , Escherichia coli Klebsiella pneumonia . The great majority infection pathogens represent asymptomatic carriage , though absence routine screen asymptomatic carriage reliable estimate prevalence , rate transmission patient , rate importation community lacking . Moreover , current understanding degree manner different antibiotic act select resistant organism rudimentary .</brief_summary>
	<brief_title>Bacterial Transmission Dynamics Study</brief_title>
	<detailed_description>Objectives : To quantify prevalence drug-resistant Gram-negative pathogen admission neonatal intensive care unit subsequent day hospital stay . To quantify rate patient-to-patient transmission key organism , characterize patient antibiotic use impact ward-level dynamic organism . Methods : All infant admit unit period one year parent/guardian give informed consent include . In addition routine demographic clinical data include patient , full patient-level data antibiotic use within ward also record . Carriage resistant Gram-negative organism determine though rectal swab , tracheal aspirate ( ventilated patient ) stool sample take admission twice weekly interval . Antibiotic-resistant Gram-negative bacteria culture resistant pattern determine . Selected environmental surface also sample detect contamination organism . For important organism ( Acinetobacter spp . Klebsiella spp . ) whole genome sequencing use conjunction Bayesian data augmentation technique determine transmission pathway impact antibiotic use transmission persistence organism within hospital ward .</detailed_description>
	<criteria>All neonate admit QSNICH NICU Parent/legal guardian give write informed consent â€¢ There exclusion criterion study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Month</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Bacterial transmission</keyword>
	<keyword>Surveillance</keyword>
	<keyword>Neonatal</keyword>
	<keyword>Drug Resistance</keyword>
</DOC>